I. Querejeta

1.6k total citations
14 papers, 1.0k citations indexed

About

I. Querejeta is a scholar working on Clinical Psychology, Psychiatry and Mental health and Health. According to data from OpenAlex, I. Querejeta has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Psychology, 4 papers in Psychiatry and Mental health and 3 papers in Health. Recurrent topics in I. Querejeta's work include Suicide and Self-Harm Studies (5 papers), Schizophrenia research and treatment (4 papers) and Substance Abuse Treatment and Outcomes (3 papers). I. Querejeta is often cited by papers focused on Suicide and Self-Harm Studies (5 papers), Schizophrenia research and treatment (4 papers) and Substance Abuse Treatment and Outcomes (3 papers). I. Querejeta collaborates with scholars based in Spain, United Kingdom and Sweden. I. Querejeta's co-authors include Javier Ballesteros, John C. Duffy, Tore Bjerke, Unni Bille‐Brahe, Armin Schmidtke, B. Temesváry, Diego De Leo, P. Crepet, Jouko Lönnqvist and A. Philippe and has published in prestigious journals such as Addiction, Journal of Epidemiology & Community Health and Acta Psychiatrica Scandinavica.

In The Last Decade

I. Querejeta

14 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Querejeta Spain 12 637 280 214 207 198 14 1.0k
Aini Ostamo Finland 24 1.4k 2.3× 228 0.8× 419 2.0× 186 0.9× 486 2.5× 43 1.9k
Eliana Greenstein United States 16 357 0.6× 589 2.1× 119 0.6× 372 1.8× 154 0.8× 20 1.2k
Marlene Stenbacka Sweden 20 300 0.5× 495 1.8× 91 0.4× 162 0.8× 62 0.3× 36 990
Hamid Ghodse United Kingdom 18 287 0.5× 298 1.1× 94 0.4× 138 0.7× 60 0.3× 69 909
Nahid Darvishi Iran 7 606 1.0× 178 0.6× 71 0.3× 88 0.4× 215 1.1× 9 757
Unni Bille‐Brahe Denmark 24 1.7k 2.6× 116 0.4× 430 2.0× 119 0.6× 570 2.9× 53 1.9k
Claudia Wells United Kingdom 13 392 0.6× 89 0.3× 68 0.3× 187 0.9× 117 0.6× 17 815
Brandon Nichter United States 18 704 1.1× 175 0.6× 64 0.3× 222 1.1× 136 0.7× 49 977
Elizabeth Bale United Kingdom 11 927 1.5× 100 0.4× 181 0.8× 73 0.4× 239 1.2× 18 1.1k
Mehran Farhadi Iran 6 520 0.8× 166 0.6× 61 0.3× 63 0.3× 181 0.9× 23 655

Countries citing papers authored by I. Querejeta

Since Specialization
Citations

This map shows the geographic impact of I. Querejeta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Querejeta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Querejeta more than expected).

Fields of papers citing papers by I. Querejeta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Querejeta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Querejeta. The network helps show where I. Querejeta may publish in the future.

Co-authorship network of co-authors of I. Querejeta

This figure shows the co-authorship network connecting the top 25 collaborators of I. Querejeta. A scholar is included among the top collaborators of I. Querejeta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Querejeta. I. Querejeta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zabala, Arantzazu, I. Querejeta, Ana González‐Pinto, et al.. (2018). Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment. Therapeutic Drug Monitoring. 40(2). 257–267. 7 indexed citations
2.
Zabala, Arantzazu, I. Querejeta, Ana González‐Pinto, et al.. (2017). A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients. Journal of Clinical Psychopharmacology. 37(5). 569–577. 16 indexed citations
3.
Horrillo, Igor, et al.. (2016). Biochemical parameters associated with neuroinflammation in depressed patients: relationship with clinical intensity. European Neuropsychopharmacology. 26. S208–S208. 1 indexed citations
4.
Sánchez‐Moreno, José, José María Villagrán Moreno, Marta Camacho, et al.. (2008). Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder. Bipolar Disorders. 10(3). 400–412. 50 indexed citations
5.
San, Luis, et al.. (2006). A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients. European Psychiatry. 21(8). 539–543. 32 indexed citations
6.
Ballesteros, Javier, et al.. (2004). Efficacy of Brief Interventions for Hazardous Drinkers in Primary Care: Systematic Review and Meta‐Analyses. Alcoholism Clinical and Experimental Research. 28(4). 608–618. 196 indexed citations
7.
Ballesteros, Javier, et al.. (2003). Brief interventions for hazardous drinkers delivered in primary care are equally effective in men and women. Addiction. 99(1). 103–108. 86 indexed citations
8.
Ballesteros, Javier, et al.. (2003). Eficacia del consejo médico para la reducción del consumo excesivo de alcohol. Metaanálisis de estudios españoles en atención primaria. Gaceta Sanitaria. 17(2). 116–122. 19 indexed citations
9.
Hultén, Agnes, D. Wasserman, Keith Hawton, et al.. (2000). Recommended care for young people (15–19 years) after suicide attempts in certain European countries. European Child & Adolescent Psychiatry. 9(2). 100–108. 29 indexed citations
10.
Michel, K., Pietro Ballinari, Unni Bille‐Brahe, et al.. (2000). Methods used for parasuicide: results of the WHO/EURO Multicentre Study on Parasuicide. Social Psychiatry and Psychiatric Epidemiology. 35(4). 156–163. 76 indexed citations
11.
Hawton, Keith, Ella Arensman, David A. Wasserman, et al.. (1998). Relation between attempted suicide and suicide rates among young people in Europe.. Journal of Epidemiology & Community Health. 52(3). 191–194. 105 indexed citations
12.
Bille‐Brahe, Unni, Kjeld Andersen, Danuta Wasserman, et al.. (1996). The WHO-EURO Multicentre Study: Risk of Parasuicide and the Comparability of the Areas Under Study. Crisis. 17(1). 32–42. 21 indexed citations
13.
Gaminde, Idoia, et al.. (1993). Depression in three populations in the Basque country —a comparison with Britain. Social Psychiatry and Psychiatric Epidemiology. 28(5). 243–251. 27 indexed citations
14.
Platt, Stephen, Unni Bille‐Brahe, A.J.F.M. Kerkhof, et al.. (1992). Parasiticide in Europe: the WHO/EURO multicentre study on parasuicide. I. Introduction and preliminary analysis for 1989. Acta Psychiatrica Scandinavica. 85(2). 97–104. 357 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026